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 Dynamin 2 (DNM2) is involved in clathrin-dependent and clathrin-independent 
endocytosis, intracellular membrane trafficking, and the regulation of actin and microtubule 
networks.  Mutations in DNM2 cause both centronuclear myopathy (CNM), a congenital 
myopathy, and Charcot-Marie-Tooth (CMT) disease, a peripheral neuropathy.  Currently, little is 
known about the function of DNM2 in neuromuscular development.  To address this limitation, 
we examined dnm2, a zebrafish homolog of DNM2.  It is shown here through protein-protein 
BLAST analysis that the zebrafish Dnm2 is highly related to human DNM2.  It is demonstrated 
that dnm2 is expressed in adult zebrafish brain, spinal cord, liver, heart, and skeletal muscle 
tissue, which is consistent with the ubiquitously expressed human DNM2.  Finally, morpholino-
mediated knockdown of dnm2 in zebrafish embryos results in the development of multiple 





 Proper turnover of membranes and the timely transport of intracellular materials are 
crucial to cellular function and survival in all cells.  Many of these tasks are facilitated by a 
family of GTPases known as dynamins
1,2
.  Of distinct interest, dynamin 2 is associated with 
clathrin-dependent and clathrin-independent endocytosis, as well as intracellular membrane 
trafficking.  This ubiquitously expressed protein has also been shown to participate in the 
regulation of actin and microtubule networks
2,3
.   The human form of this gene is located on the 
short arm of chromosome 19, encompassing a 114-kilobase region with 22 exons
2
.  
Combinations of alternative splicing at two sites yield four distinct isoforms of DNM2
2
.  In the 
rat, all four isoforms are expressed in cerebral tissue
4
.  Though the exact isoform expression 
pattern is unknown in humans, all four isoforms are expressed in human muscle and peripheral 
nerve tissue
2
.  The DNM2 protein consists of five distinct domains: GTPase domain, Middle 
domain, Pleckstrin Homology domain (PH), GTPase Effector Domain (GED), and a Proline-
Rich Domain (PRD)
2,5
 (See Fig. 1A).    
The DNM2 gene is an intriguing target worthy of neuroscientific examination because 
mutations in this gene cause two different human neuromuscular diseases (See Fig. 1A).  
Recently, mutations in DNM2 have been implicated in the pathogenesis of Charcot-Marie-Tooth 
(CMT) disease, a genetically heterogeneous peripheral neuropathy characterized by progressive 
muscle weakness of the extremities
2,6,7
.  DNM2 mutations have also been linked to both familial 
and sporadic forms of centronuclear myopathy (CNM), a congenital myopathy
2,8
.  As of yet, 
little is known about the function of DNM2 in neuromuscular development and maintenance.  
Knockout of DNM2 in mice results in early lethality
9
, which provides little information about the 
4 
 
specific role of DNM2 during development.  In order to address this obstacle, this study proposes 
to use morpholino-mediated knockdown of dnm2 in the piscine model Danio rerio. 
 Morpholino phosphordiamidate oligonucleotides (morpholinos; MOs) are stable 
uncharged water-soluble nucleic acid analogues that bind to complimentary sequences of RNA
10
.  
Due to the high binding affinity of MOs for RNA, these 25-subunit molecules are highly 
effective genetic targeting tools
11
.  Morpholinos are commonly used for mRNA translation 
inhibition or alternative splicing of pre-mRNA
10
.  Morpholinos are frequently employed to 
knockdown genes that function in early development and are effectively used in embryonic 
studies of animal models such as Xenopus and Danio rerio
10,11
.  MOs are typically delivered to 
embryos by microinjection at the 1-4 cell stage
10
.  Progeny of injected cells contain the desired 
oligos, and depending on the relative permeability of a species’ embryonic cells, MOs may 
diffuse and be taken up by surrounding un-injected cells within the same embryo, a feature 
common to zebrafish
10
.   
Because mutations in the DNM2 gene are linked to diseases affecting two essential 
biological systems, it is important to learn more about the specific function of DNM2 itself.  An 
enhanced understanding of a piscine DNM2 will pave the way for the generation of successful 
models of DNM2- related disorders in zebrafish.  This study establishes the general organization, 








Methods and Materials 
Danio rerio 
 Zebrafish were maintained in compliance with all standards set by the University of 
Michigan Institutional Animal Care and Use Committee (UCUCA).  Wild type (AB strain) 
zebrafish were used in all experiments.  Embryos were collected after timed mating of adult 
zebrafish.   
Protein Homology Analysis 
 Human DNM2 isoform 1 and zebrafish Dnm2 amino acid sequences were compared for 
percent homology.  Sequences were obtained from the NCBI protein database.  Following the 
respective posted annotations, sequences were divided by domain (GTPase, Middle, PH, GED, 
and PRD) and compared using the Blastp algorithm through NCBI’s Basic Local Alignment 
Search Tool (BLAST).  BLAST identities are defined as the fraction of total residues which are 
identical.  BLAST positives are the fraction of residues for which alignment scores have positive 
values.  The most recent annotated version of the zebrafish Dnm2 amino acid sequence available 
through NCBI does not include the entire Proline-Rich Domain sequence, so homology analysis 
was performed on a comparable segment (22 amino acids) of the human PRD region.   
Morpholinos 
 A splice-targeting morpholino (MO
dnm2
) was designed against the donor site of exon 2 of 
the zebrafish dnm2 (5’-TGCCGTGCTCATTAACACACTCACC-3’). A standard control (MO
Ctl
) 
was also used (5’-CCTCTTACCTCAGTTACAATTTATA-3’) which is targeted against a 
splice-site mutant unique to human beta-globin in thalassemia
12
 and has no significant biological 




Microinjection and Embryo Collection 





 were injected at .3mM concentration.  Constructs were injected into the yolk 
sack embryos at the 1-2 cell stage.  Embryos were cultivated in E2 media until 24hpf.  Before 
processing, embryos were manually dechorionated using fine forceps.   
RNA Extraction and RT-PCR 
 Total cellular RNA was extracted from separate batches of 20 dechorionated 24hpf 
embryos using a QIAGEN RNeasy Mini RNA isolation kit per the manufacturer’s protocol.   
cDNA was reverse-transcribed from 500ng total RNA using a BioRad iScript cDNA synthesis 
kit following the manufacturer’s instructions.  PCR was performed using dnm2 or ef1α (control) 
primers: 
dnm2 forward:  GGCCAAAGTTGTAACCTGGA 
dnm2 reverse:   CGGTTTCTGCTTCAATCTCC 
ef1α forward:  TCACCCTGGGAGTGAAACAGC 
ef1α reverse:  ACTTGCAGGCGATGTGAGCAG 
PCR cycles were performed as follows:  95°C for 4 min, 30 cycles of 95°C for 30 s, 60°C for 30 
s, and 72°C for 30 s.   
 Total cellular RNA was extracted from adult brain, spinal cord, liver, heart, and muscle 
tissue isolated from 6 month-old AB fish.  RT-PCR protocols listed above were utilized, and 
cDNA products were run on 1% agarose gels.  For developmental experiments, amplified cDNA 
products were analyzed via gel electrophoresis and run on 1% agarose gels. 
 For morpholino experiments, injected 24hpf embryos were processed using the described 
QIAGEN and BioRad protocols and amplified using dnm2 or ef1α primers.  cDNA products 
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were run initially on 1.5% agarose gels, but later 3.0% low melting point agarose gels were used 
for better separation.  Distinct bands were excised and cDNA was extracted using the QIAquick 
Gel Extraction Kit (QIAGEN) per the manufacturer’s instructions.  cDNA sequencing was 





Protein Homology Analysis 
 Protein-protein BLAST analyses of the GTPase, Middle, PH, GED, and PRD domains 
show that human DNM2 and zebrafish Dnm2 have identities of 90%, 90%, 93%, 87 %, and 
83%, and positive values of 90%, 97%, 99%, 95%, and 95% for the respective domains (See 
Figs. 1B-C). 
DNM2 Adult Tissue Expression  
 RT-PCR analysis of adult zebrafish tissue reveals that dnm2 is expressed in all five 
tissues.  Expression was observed in liver, lung, spinal cord, brain, and skeletal muscle tissues 
(See Fig. 2).   
DNM2 Morpholino-mediated Knock Down 
 An abnormal phenotype is observed in MO
dnm2
 zebrafish larvae at 24hpf (See Fig 3D).  
The MO
dnm2
 larvae exhibit shortened body length, increased spinal curvature, reduced blood 
flow, pericardial edema, and yolk sac edema.   
 RT-PCR and gel electrophoresis confirmed dnm2 knockdown in the 24hpf MO
dnm2
 larvae 
as compared to MO
Ctl




 cDNA amplified 
using ef1α control primers exhibited bands of identical sizes.  MO
Ctl
 cDNA amplified using 
dnm2 primers exhibited a single band of length 247bp, whereas MO
dnm2
 cDNA produced three 
bands of 173bp , 247bp, and 291bp respectively (See Figs. 3A-B).  Sequencing of the longest 
MO
dnm2
 band, 291bp in length, reveals that it consists of an unexpected splice variant in which 
exons 1-3 are expressed intact, but includes a short intronic segment between exons 2 and 3 (See 





 DNM2 is an important target for neuroscientific investigation because mutations in the 
human DNM2 gene are implicated in two neuromuscular diseases.  The significance of DNM2 is 
further supported by the crucial role that the DNM2 protein plays in proper cellular function.  
Here it is shown by protein-protein BLAST comparison that the Dnm2 homologue in Danio 
rerio is highly related to the human DNM2 isoform1 at the level of translation.  The high 
percentage of identical amino acids in each of the protein’s five domains suggests strong 
conservation of Dnm2 protein structure across these two vertebrate species.  Furthermore, it is 
unlikely that either gene has experienced dramatic recombination because the observed positive 
percentages indicate high fidelity of amino acid sequence alignment.  Such evidence validates 
the use of zebrafish dnm2 in order to better understand DNM2.   
 RT-PCR was performed on brain, spinal cord, skeletal muscle, heart, and liver tissue in 
order to investigate the expression pattern of dnm2 in adult zebrafish.  We have shown that dnm2 
is expressed in all five tissues.  This finding is consistent with expression patterns observed in 
other species, such as humans, in which DNM2 is ubiquitously expressed
1
.  This further supports 
the use of dnm2 as a model for investigation of DNM2. 
 In order to better understand the developmental role of DNM2, morpholinos were 
designed to knockdown dnm2 expression in zebrafish embryos.  Morpholinos are highly 
effective pre-mRNA alternative splicing modifiers, making them useful tools to mediate the 
knockdown of gene expression
10,11
.  Naturally, alternative splicing is under the direction of small 
nuclear ribonucleoproteins (snRNPs) which bind to introns, marking intron/exon boundaries
10
.  
MOs designed to target these native snRNP-binding sites can redirect splicing to produce 





.  By blocking a native snRNP-binding site, a cryptic splice site can become 
activated which may complicate the interpretation of splice products due to possible partial 
deletions of exons or partial inclusions of introns
10
.  Efficacy of splice alteration can easily be 
monitored by RT-PCR techniques
10,11
.   
 We found that MO knockdown in zebrafish embryos targeting dnm2 pre-mRNA causes 
an abnormal developmental phenotype.   As compared to MO
Ctl
 injected embryos, MO
dnm2
 
injected embryos develop shortened body lengths, increased spinal curvature, reduced blood 
flow, pericardial edema, and yolk sac edema. These dramatic anatomical defects suggest a 
significant role for dnm2 in the early development of zebrafish.  MO
dnm2 
is designed to modify 
alternative splicing such that exon 2 of dnm2 is omitted and the following exons are out of frame.   
The expected lengths of the natural RT-PCR product and the truncated product are 247bp and 
173bp.  Knockdown efficiency was confirmed by RT-PCR (See Fig. 3A).  Though the two 
expected band lengths were observed on a 1.5% agarose gel, there appeared to be an additional 
band of longer length.   
 To identify and confirm the extra band’s existence, amplified cDNA was run on a 3% 
gel, and indeed a third band 291bp in length was easily discerned (See Fig. 3B).  This third band 
was excised and extracted from the gel.  Sequencing revealed that for this transcript, the MO
dnm2
 
failed to target the exon2 splice site, but instead activated an intronic cryptic splice site 
downstream from exon 2 (See Figs. 4A, 4D, and 5).  The included intronic sequence introduces 
an early stop codon, preventing the final mRNA product from proper translation (See Fig. 5).   
This further suggests that the observed morphant phenotype is indeed the result of dnm2 
knockdown rather than a possible dominant-negative effect carried out by a product of the 
unexpected third transcript.   
11 
 
 This project has successfully shown through protein-protein BLAST analysis that the 
human and zebrafish homologues are highly related.  We have demonstrated that morpholino 
mediated knockdown of dnm2 results in a dramatic phenotype in which larvae exhibit multiple 
developmental deficiencies.  RT-PCR analysis indicates that dnm2 is expressed in many types of 
adult zebrafish tissues.  Overall, zebrafish dnm2 offers a promising model for which to learn 
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Figure 1.  DNM2 mutations and homology.  A) Schematic organization of human DNM2 
showing five protein domains and positions of seventeen disease-associated mutations.  
Mutations above the schematic are related to centronuclear myopathy, and those below it are 
associated with Charcot-Marie-Tooth disease.  B-C) Schematic organization of protein-protein 
BLAST comparison between human DNM2 and zebrafish Dnm2. The green labeled PRD 
domains in B and C are truncated as compared to that illustrated in A due to limitations in public 
records of the zebrafish Dnm2 PRD.  The available zebrafish PRD sequence was instead 
compared to an equivalent length segment of the human DNM2 PRD sequence.  B) Percentage 
of identical residues between respective domains. C) Fraction of residues for which alignment 








Figure 2.  Expression of dnm2 in adult zebrafish.  RT-PCR was used to assay expression levels 
of dnm2 in tissues isolated from adult zebrafish six months of age.  Primers for ef1α were used as 




Figure 3.  Morpholino-mediated knockdown of dnm2 in zebrafish embryos.  A)  RT-PCR was 
used to evaluate knockdown efficiency of MO
dnm2
 in 24hpf embryos as compared to those 
microinjected with MO
Ctl
.  The presence of two bands of lengths 173bp and 247bp confirm dnm2 
knockdown.  A possible longer third band was observed (see orange arrow).  B)  For improved 
resolution, cDNA from embryos injected with MO
dnm2
 was run on a higher density agarose gel.  
The presence of a third band of length 291bp was confirmed (see orange arrow).  C)  Side by 
side phenotypic comparison of a 48hpf zebrafish: wild type larva (top), and a MO
dnm2
 injected 
larva (bottom).  D)  Zebrafish embryos injected with MO
dnm2
 develop an abnormal phenotype 
observed here at 24hpf.  This phenotype is characterized by shortened body length, increased 








Figure 4.  Schematic representation of morpholino-mediated alternative splicing of dnm2 pre-
mRNA.  A) Illustration of splicing interactions as they relate to the first three exons of dnm2.  
Black bar above exon 2 denotes the intron/exon boundary targeted by MO
dnm2
.  The set of green 
lines indicate the wild type splicing mechanism (see schematic mRNA product B).  The blue 
lines indicate the expected MO
dnm2
 mediated splicing mechanism in which the second exon is 
omitted (see mRNA schematic C).  The set of red lines indicate the mechanism by which an 
activated cryptic splice site redirects alternative splicing, resulting in the addition of an intronic 
segment (see schematic mRNA product D; intronic region denoted by asterisk).  B) wild type 
dnm2 mRNA  C) MO
dnm2
 mediated alternative splicing produces a truncated dnm2 mRNA D) 
Alternative morpholino-mediated splice product in which an activated cryptic splice site allows 
the transcript to retain exons 1-3, but appends an intronic segment downstream of exon 2 











  Exon 1  Exon 2  Exon 3  Intronic Sequence  Early Stop Codon 
 
Figure 5.  Sequence of the 291bp RT-PCR product includes an unexpected intronic region 
(denoted in black) as a result of an activated cryptic splice site.  The intronic region introduces an 
early stop codon (denoted in red)  which prevents proper translation of the transcript.  This 
indicates that the abnormal phenotype observed in MO
dnm2
 injected embryos is a result of dnm2 
knockdown as opposed to a dominant-negative effect imposed by the alternative transcript. 
